Literature DB >> 22647863

Prevalence of musculoskeletal diseases in Guatemala, Central America: the COPCORD study of 2 populations.

Ariel Obregón-Ponce1, Isa Iraheta, Helga García-Ferrer, Bayardo Mejia, Abraham García-Kutzbach.   

Abstract

BACKGROUND: Guatemala is a multiethnic, multilingual, and multicultural country. We have evaluated 2 different ethnic groups from (1) San Juan Sacatepéquez County (SJSC), a rural population (30% illiterate), with 65% from Kaqchiquel ethnic group; and (2) Zone 5 of Guatemala City (Z5GC), an urban population (6.6% illiterate), with 95.5% mestizos.
OBJECTIVE: This study aimed to measure simultaneously the prevalence of rheumatic diseases in these 2 Guatemalan populations, both located in the State of Guatemala.
METHODS: A convenience sample of 4000 inhabitants 15 years and older was selected in each group. The Core Community Oriented Program for Control of Rheumatic Diseases Questionnaire was used in this survey. Phase 1 was for screening (identification of study subjects), phase 2 was for obtaining information from subjects with musculoskeletal complaints, and phase 3 was for rheumatologic diagnostic purposes. Phases 1 and 2 were performed by 6 interviewers. Phase 3 was completed by 4 rheumatologists.
RESULTS: In phase I, 8000 subjects were identified in both groups. In phase II, 949 subjects reported musculoskeletal complaints: 371 (39%) in Z5GC and 578 (61%) in SJSC. In phase III, 419 patients were clinically evaluated: 141 (34%) in Z5GC and 278 (66%) in SJSC. The most prevalent musculoskeletal diseases were (1) osteoarthritis, (2) soft tissue rheumatism, (3) rheumatoid arthritis, (4) low back pain, and (5) arthralgias of unknown etiology. Osteoarthritis and soft tissue rheumatism were significantly more common in the rural population.
CONCLUSIONS: The most prevalent musculoskeletal diseases in Guatemala seem to be similar to those in most previous Community Oriented Program for Control of Rheumatic Diseases studies. Most subjects were still working. Further studies examining medical care received and impact on function can now be of interest.

Entities:  

Mesh:

Year:  2012        PMID: 22647863     DOI: 10.1097/RHU.0b013e3182583803

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  17 in total

1.  Culture-sensitive adaptation and validation of the community-oriented program for the control of rheumatic diseases methodology for rheumatic disease in Latin American indigenous populations.

Authors:  Ingris Peláez-Ballestas; Ysabel Granados; Adriana Silvestre; José Alvarez-Nemegyei; Evart Valls; Rosana Quintana; Yemina Figuera; Flor Julian Santiago; Mario Goñi; Rosa González; Natalia Santana; Romina Nieto; Irais Brito; Imelda García; Maria Cecilia Barrios; Manuel Marcano; Adalberto Loyola-Sánchez; Ivan Stekman; Marisa Jorfen; Maria Victoria Goycochea-Robles; Fadua Midauar; Rosa Chacón; Maria Celeste Martin; Bernardo A Pons-Estel
Journal:  Rheumatol Int       Date:  2014-03-29       Impact factor: 2.631

Review 2.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 3.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

4.  Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study.

Authors:  Ysabel Granados; Ligia Cedeño; Celenia Rosillo; Sol Berbin; Miriam Azocar; María Elena Molina; Onelia Lara; Gloris Sanchez; Ingris Peláez-Ballestas
Journal:  Clin Rheumatol       Date:  2014-06-13       Impact factor: 2.980

5.  The Global Spine Care Initiative: a systematic review of individual and community-based burden of spinal disorders in rural populations in low- and middle-income communities.

Authors:  Eric L Hurwitz; Kristi Randhawa; Paola Torres; Hainan Yu; Leslie Verville; Jan Hartvigsen; Pierre Côté; Scott Haldeman
Journal:  Eur Spine J       Date:  2017-12-27       Impact factor: 3.134

6.  Prevalence of musculoskeletal symptoms in the five urban regions of Brazil-the Brazilian COPCORD study (BRAZCO).

Authors:  Edgard Torres Dos Reis-Neto; Marcos Bosi Ferraz; Sérgio Candido Kowalski; Geraldo da Rocha Castelar Pinheiro; Emilia Inoue Sato
Journal:  Clin Rheumatol       Date:  2015-05-12       Impact factor: 2.980

7.  Contribution of ethnic group and socioeconomic status to degree of disability in rheumatoid arthritis in Chilean patients.

Authors:  Ana M Alarcón; Sergio Muñoz; Jay S Kaufman; Carlos Martínez; Pablo Riedemann; Sonia Kaliski
Journal:  Rheumatol Int       Date:  2014-09-02       Impact factor: 2.631

8.  Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study.

Authors:  Sergio Guevara-Pacheco; Astrid Feicán-Alvarado; Luz Helena Sanín; Jaime Vintimilla-Ugalde; Fernando Vintimilla-Moscoso; Jorge Delgado-Pauta; Angelita Lliguisaca-Segarra; Holger Dután-Erráez; Daniel Guevara-Mosquera; Verónica Ochoa-Robles; Mario H Cardiel; Ingris Peláez-Ballestas
Journal:  Rheumatol Int       Date:  2016-03-29       Impact factor: 2.631

9.  Effect of informal employment on the relationship between psychosocial work risk factors and musculoskeletal pain in Central American workers.

Authors:  David Gimeno Ruiz de Porras; Marianela Rojas Garbanzo; Aurora Aragón; Lino Carmenate-Milián; Fernando G Benavides
Journal:  Occup Environ Med       Date:  2017-04-25       Impact factor: 4.402

10.  Low back pain among office workers in three Spanish-speaking countries: findings from the CUPID study.

Authors:  Adriana Campos-Fumero; George L Delclos; David I Douphrate; Sarah A Felknor; Sergio Vargas-Prada; Consol Serra; David Coggon; David Gimeno Ruiz de Porras
Journal:  Inj Prev       Date:  2016-09-01       Impact factor: 2.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.